Sally Hall

Doctor of Osteopathic Medicine,  CharitĂ© - Universitätsmedizin Berlin 

Location: United States

Consulting Services

Case Consulting Scientific Writing

Areas Of Interest

Research Errors Hyperinsulinism, Familial, with Pancreatic Nesidioblastosis Technology, Enhancement Mesoplastics Interaction, Gene-Environment Maternal Welfare Bone Tunnel Widenings Abscesses, Intracranial Extradural Optic Atrophies, Dominant Environments, Controlled Sialadenitides, Chronic Cells, Grid v erbA Proteins Anti Angiogenic Drugs Health Care, Preventive delta Chains, Ig BI 1356 Arsphenamine TC48 Enzyme Sleep Apnea Syndrome, Obstructive RNA Precursor Paget's Disease, Extramammary Antineoplastic Antibiotics Crises, Asthmatic Species, Sympatric Amino Acids, Essential Ozenas Receptors, Pancreatic Hormones Epidermoid Cyst Cessation of Treatment Indexes, Health Status Gene, Sex-Determining Region Y Umbilical Cords Bleomycin A2 Anti Anxiety Drugs Psoas Abscesses D-Alanine Transaminase Flukes, Liver Law, Constitutional Densitometry, X Ray

Professional Narrative

Dr. Sally Hall was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Hall has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Medical Writer, Mayo Clinic 2000
Executive Director, Mayo Clinic 1997

Education

Bachelor of science in nursing, Harvard Medical School 1997
Director Medicine, Perelman School of Medicine 2007

Referees


Publications

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :